In our study, to determine the reason why the combination of the CCL11-E6E7 vaccine and PD-1 is not effective, further tests are needed to determine whether the tumor specific T cells induced by DNA vaccines are in a PD-1-responsive state. The gene discussed is CCL11; the disease is neoplasm.